| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | -100.0% | — |
| Cost of Revenue | $22K | +3.7% | -58.6% |
| Gross Profit | -$22K | -46.1% | +58.6% |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $403K | -17.0% | -45.5% |
| Operating Income | -$425K | +15.1% | +49.7% |
| Net Income | -$430K | +13.7% | +48.8% |
| EPS (Basic) | -$0.04 | +20.0% | +50.0% |
| EPS (Diluted) | -$0.04 | +20.0% | +50.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $0 | -100.0% | — |
| Inventory | $566K | +7.8% | -66.5% |
| Current Assets | $77K | +5.2% | -78.7% |
| Total Assets | $701K | +6.4% | -66.9% |
| Current Liabilities | $595K | +29.2% | +248.7% |
| Total Liabilities | $847K | +48.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$465K | -103.5% | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $432K | +105.8% | — |
| Free Cash Flow | -$465K | -103.5% | — |
| +213.1% |
| Stockholders' Equity | -$133K | -237.6% | -107.3% |